Hepatitis D
Acta virologica.
2005 ;
49 (4) :
219-25.
Language English Country Switzerland Media print
Document type Journal Article, Review
Persistent link
https://www.medvik.cz/link/pmid16402678
PubMed
16402678
Knihovny.cz E-resources
- MeSH
- Antiviral Agents therapeutic use MeSH
- Models, Biological MeSH
- Hepatitis B complications MeSH
- Hepatitis D * complications diagnosis drug therapy epidemiology MeSH
- Interferon-alpha therapeutic use MeSH
- Humans MeSH
- Hepatitis Delta Virus pathogenicity physiology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Names of Substances
- Antiviral Agents MeSH
- Interferon-alpha MeSH
Hepatitis D virus (HDV) is a small, RNA-containing virus that requires the concomitant presence of Hepatitis B virus (HBV) in an obligate manner for its survival and pathogenicity. HDV infection is very uncommon in Czech Republic. The results of antiviral therapy of hepatitis D patients are not satisfactory. Alpha-interferon (alpha-IFN) in high doses (9-10 MU three times a week for 12 months) is usually recommended.
